BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 16123960)

  • 1. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW
    Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
    Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC
    J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.
    Troisi R; Defreyne L; Hesse UJ; Praet M; Decruyenaere J; De Hemptinne B
    Clin Transplant; 1998 Aug; 12(4):313-9. PubMed ID: 9686325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
    Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.